Inherited thyroid metabolism disease
MONDO:0045046An inherited metabolic disease that is has its basis in the disruption of thyroid hormone metabolic process.
Also known as: inborn error of thyroid hormone metabolic process, inborn thyroid hormone metabolic process disorder, inherited disorder of thyroid metabolism, rare inborn error of thyroid hormone metabolic process
8 clinical trials for this condition and its sub-types, 0 tagged with Inherited thyroid metabolism disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inherited thyroid metabolism disease
-
Thyroid hormone resistance syndrome 3 trials · 4 incl. sub-types
4 sub-types
- Generalized resistance to thyroid hormone 1 trial · 2 incl. sub-types Sub-types →
- Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta 1 trial · 2 incl. sub-types Sub-types →
- Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha 1 trial
- Selective peripheral resistance to thyroid hormone 0 trials
-
Familial thyroid dyshormonogenesis 1 trial · 4 incl. sub-types
6 sub-types
- Thyroid dyshormonogenesis 2A 4 trials
- Thyroid dyshormonogenesis 1 1 trial
- Thyroid dyshormonogenesis 3 1 trial
- Thyroid dyshormonogenesis 5 1 trial
- Thyroid dyshormonogenesis 6 1 trial
- Thyroid dyshormonogenesis 4 0 trials
Most studied deeper sub-types
-
Stem cell hope for rare brain disease: new expanded access trial opens
Disease control Expanded accessThis study offers expanded access to an experimental stem cell treatment for up to 7 adults with Multiple System Atrophy (MSA), a rare and serious brain disorder. Participants will receive 12 intravenous infusions and 6 spinal injections of donor stem cells over 44 weeks. The goa…
Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New protein therapy hopes to repair brain damage in rare disease
Disease control Recruiting nowThis early-phase trial tests a drug called Aleeto, a nerve repair protein made from stem cells, in 20 people with Multiple System Atrophy (MSA), a rare brain disease. The study checks if Aleeto is safe and might help with symptoms. Participants receive the drug via injection into…
Early phase 1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:56 UTC
-
Blood test breakthrough could spot Parkinson's before symptoms worsen
Diagnosis Recruiting nowThis study is testing a new blood test to help doctors diagnose Parkinson's disease and similar brain disorders more accurately and earlier. Researchers will use a technique called RT-QuIC to detect misfolded proteins in blood samples from 458 participants, including healthy peop…
Sponsor: Xuanwu Hospital, Beijing • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Scientists watch thyroid conditions unfold in 2,500 patients
Knowledge-focused Recruiting nowThis study follows up to 2,500 people with thyroid problems like hyperthyroidism, hypothyroidism, or Graves' disease. Researchers will track how these conditions develop over time using standard medical tests and genetic samples. The goal is to better understand the natural histo…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New study aims to unlock mysteries of rare thyroid condition
Knowledge-focused Recruiting nowThis observational study will enroll 150 people to better understand thyroid hormone resistance syndromes, rare conditions where the body does not respond properly to thyroid hormone. Researchers will use genetic testing, blood analysis, and lab-grown cells to find better ways to…
Sponsor: Istituto Auxologico Italiano • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:55 UTC